急性移植物抗宿主病的病理生理、预防和治疗

IF 0.1 Q4 TRANSPLANTATION Transplant Research and Risk Management Pub Date : 2011-03-07 DOI:10.2147/TRRM.S11989
A. Deol, V. Ratanatharathorn, J. Uberti
{"title":"急性移植物抗宿主病的病理生理、预防和治疗","authors":"A. Deol, V. Ratanatharathorn, J. Uberti","doi":"10.2147/TRRM.S11989","DOIUrl":null,"url":null,"abstract":"Correspondence: Joseph P Uberti Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer institute, wayne State University School of Medicine, Detroit, Mi 48201, USA Tel +1 313 576 8760 Fax +1 313 576 8766 email ubertij@karmanos.org Abstract: Acute graft-versus-host disease (aGVHD) is an immunologically mediated inflammatory reaction, which continues to be a major cause of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplant. Although the occurrence and severity of this disease may be devastating, there is a proven immunologically mediated antitumor activity that accompanies the disease process, which has a beneficial effect on outcome. Animal models of graft-versus-host disease (GVHD) have given us a conceptual model that has allowed a better understanding of the pathophysiology and offers a framework for understanding the complex interactions between antigen-presenting cells, donor T-cells, and cytokines in the development of aGVHD. It has also given us a model that allows testing of various strategies for prevention and treatment. New, innovative approaches for treatment and prevention of aGVHD including better donor selection with the use of sophisticated human leukocyte antigen typing, use of T-cell depletion, reduced-intensity transplant regimens, and improved pharmacologic immunosuppression have improved outcomes by decreasing the incidence and severity of aGVHD. However, the limitation of these strategies is that effective treatment and prevention of aGVHD is often accompanied by a concomitant rise in relapses, graft failure and infections, and ultimately no improvement in overall survival. Investigators are working on understanding the difference between GVHD and graft versus tumor effect, as this would be the key in improving outcomes for our patients. In this review, we will discuss the pathophysiology of aGVHD along with the preventative and treatment strategies.","PeriodicalId":41597,"journal":{"name":"Transplant Research and Risk Management","volume":"3 1","pages":"31-44"},"PeriodicalIF":0.1000,"publicationDate":"2011-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/TRRM.S11989","citationCount":"2","resultStr":"{\"title\":\"Pathophysiology, prevention, and treatment of acute graft-versus-host disease\",\"authors\":\"A. Deol, V. Ratanatharathorn, J. Uberti\",\"doi\":\"10.2147/TRRM.S11989\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Correspondence: Joseph P Uberti Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer institute, wayne State University School of Medicine, Detroit, Mi 48201, USA Tel +1 313 576 8760 Fax +1 313 576 8766 email ubertij@karmanos.org Abstract: Acute graft-versus-host disease (aGVHD) is an immunologically mediated inflammatory reaction, which continues to be a major cause of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplant. Although the occurrence and severity of this disease may be devastating, there is a proven immunologically mediated antitumor activity that accompanies the disease process, which has a beneficial effect on outcome. Animal models of graft-versus-host disease (GVHD) have given us a conceptual model that has allowed a better understanding of the pathophysiology and offers a framework for understanding the complex interactions between antigen-presenting cells, donor T-cells, and cytokines in the development of aGVHD. It has also given us a model that allows testing of various strategies for prevention and treatment. New, innovative approaches for treatment and prevention of aGVHD including better donor selection with the use of sophisticated human leukocyte antigen typing, use of T-cell depletion, reduced-intensity transplant regimens, and improved pharmacologic immunosuppression have improved outcomes by decreasing the incidence and severity of aGVHD. However, the limitation of these strategies is that effective treatment and prevention of aGVHD is often accompanied by a concomitant rise in relapses, graft failure and infections, and ultimately no improvement in overall survival. Investigators are working on understanding the difference between GVHD and graft versus tumor effect, as this would be the key in improving outcomes for our patients. In this review, we will discuss the pathophysiology of aGVHD along with the preventative and treatment strategies.\",\"PeriodicalId\":41597,\"journal\":{\"name\":\"Transplant Research and Risk Management\",\"volume\":\"3 1\",\"pages\":\"31-44\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2011-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/TRRM.S11989\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplant Research and Risk Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/TRRM.S11989\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"TRANSPLANTATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant Research and Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/TRRM.S11989","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 2

摘要

通讯:Joseph P Uberti肿瘤学系,血液和骨髓干细胞移植项目,Barbara Ann Karmanos癌症研究所,韦恩州立大学医学院,底特律,Mi 48201,美国电话+1 313 576 8760传真+1 313 576 8766邮箱ubertij@karmanos.org急性移植物抗宿主病(aGVHD)是一种免疫介导的炎症反应,它仍然是异体造血干细胞移植患者发病和死亡的主要原因。尽管这种疾病的发生和严重程度可能是毁灭性的,但已证实免疫介导的抗肿瘤活性伴随疾病过程,这对结果有有益的影响。移植物抗宿主病(GVHD)的动物模型为我们提供了一个概念模型,使我们能够更好地理解病理生理学,并为理解抗原呈递细胞、供体t细胞和细胞因子在aGVHD发展中的复杂相互作用提供了一个框架。它还为我们提供了一个模型,可以测试各种预防和治疗策略。新的、创新的治疗和预防aGVHD的方法包括更好的供体选择,使用复杂的人类白细胞抗原分型,使用t细胞耗损,降低强度的移植方案,以及改进的药理学免疫抑制,通过降低aGVHD的发病率和严重程度,改善了结果。然而,这些策略的局限性在于,aGVHD的有效治疗和预防往往伴随着复发、移植物衰竭和感染的增加,最终没有改善总生存期。研究人员正在努力了解GVHD和移植物抗肿瘤效应之间的差异,因为这将是改善患者预后的关键。在这篇综述中,我们将讨论aGVHD的病理生理以及预防和治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Pathophysiology, prevention, and treatment of acute graft-versus-host disease
Correspondence: Joseph P Uberti Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer institute, wayne State University School of Medicine, Detroit, Mi 48201, USA Tel +1 313 576 8760 Fax +1 313 576 8766 email ubertij@karmanos.org Abstract: Acute graft-versus-host disease (aGVHD) is an immunologically mediated inflammatory reaction, which continues to be a major cause of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplant. Although the occurrence and severity of this disease may be devastating, there is a proven immunologically mediated antitumor activity that accompanies the disease process, which has a beneficial effect on outcome. Animal models of graft-versus-host disease (GVHD) have given us a conceptual model that has allowed a better understanding of the pathophysiology and offers a framework for understanding the complex interactions between antigen-presenting cells, donor T-cells, and cytokines in the development of aGVHD. It has also given us a model that allows testing of various strategies for prevention and treatment. New, innovative approaches for treatment and prevention of aGVHD including better donor selection with the use of sophisticated human leukocyte antigen typing, use of T-cell depletion, reduced-intensity transplant regimens, and improved pharmacologic immunosuppression have improved outcomes by decreasing the incidence and severity of aGVHD. However, the limitation of these strategies is that effective treatment and prevention of aGVHD is often accompanied by a concomitant rise in relapses, graft failure and infections, and ultimately no improvement in overall survival. Investigators are working on understanding the difference between GVHD and graft versus tumor effect, as this would be the key in improving outcomes for our patients. In this review, we will discuss the pathophysiology of aGVHD along with the preventative and treatment strategies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
6
审稿时长
16 weeks
期刊最新文献
Tacrolimus Trough Level Variation and Its Correlation to Clinical Outcomes and Consequences in Solid Organ Transplantation Kidney Transplant Recipients with JC Virus Infection Have Decreased Function of the Transplanted Kidney A Unique Case of Tacrolimus-Induced Dysphagia and Dysarthria in the Absence of Diagnostic Findings Predictive Value of Delayed Graft Function Definitions Following Donation After Circulatory Death Renal Transplantation in the United Kingdom Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1